BamSEC and AlphaSense Join Forces
Learn More

Raphael Pharmaceutical Inc Com

OTC: RAPH    
Share price (8/5/25): $0.22    
Market cap (8/5/25): $4.318 million

Material Contracts Filter

EX-10.1
from 10-Q 17 pages Form of Subscription Agreement
12/34/56
EX-10.9
from 10-K 3 pages Director and Chairman of the Board Services Agreement
12/34/56
EX-10.8
from 10-K 3 pages This Service Agreement (This "Agreement") Is Made as of March 10, 2025, by and Between Raphael Pharmaceutical Inc. (The "Company"), and Prof. Eliya Yehuda I.D 025721069, an Individual Residing in Israel (The "Director"/So Called “Yehuda”). Recitals 1. Appointment of Director; Relationship of Company and Yehuda
12/34/56
EX-10.7
from 10-K 4 pages This Service Agreement (This “Agreement”) Is Made as of 3rd of March, 2025, by and Between Raphael Pharmaceutical Inc. (The “Company”), and Dr. Igal Louria Hayon, an Individual Residing at Israel (The “Cto”/So Called “Igal”). Recitals 1. Appointment of Igal to Be Cto & Director; Relationship of Company and Igal
12/34/56
EX-10.6
from 10-K 4 pages This Operations Agreement (This “Agreement”) Is Made as of March, 3rd ,2025, by and Between Raphael Pharmaceutical Ltd. (The “Company”), and Model Engineering & Investments. Srl a Romanian Company No. J40/1123/2007 and/or Adv’ Guy Ofir I.D. 172910400069, an Individual Residing at Romaina (The “CFO, Legal Adviser & Director”). Recitals 1. Appointment of CFO, Legal Adviser & Director and It’s Relationship With the Company
12/34/56
EX-10.5
from 10-K 5 pages This Management and Operations Agreement (This “Agreement”) Is Made as of March 3rd 2025, by and Between Raphael Pharmaceutical Ltd. (The “Company”), and Sheffa Enterprises, Inc., a New Jersey Corporation/ Shlomo Pilo, an Individual Residing at Israel (The “Manager”). Recitals 1. Appointment of Manager; Relationship of Company and the Manager
12/34/56
EX-10.4
from 10-K 1 page Extension of Appointment as a Member of the Board of Directors
12/34/56
EX-10.1
from 8-K/A 5 pages This Service Agreement (This “Agreement”) Is Made as of 5th of July, 2022, by and Between Raphael Pharmaceutical Inc. (The “Company”),, and Dr. Igal Louria Hayon (The “Cto”/So Called “Igal”). Recitals 1. Appointment of Igal to Be Cto & Director; Relationship of Company and Igal
12/34/56
EX-10.1
from 10-Q 7 pages Appendix to the Agreement Date July 07, 2019 Signed at October 23, 2022
12/34/56
EX-10.5
from 8-K 3 pages This Service Agreement (This “Agreement”) Is Made as of July 5th, 2022, by and Between Raphael Pharmaceutical Inc. (The “Company”), and Eliya Yehuda I.D 025721069, (The “Director”/So Called “Yehuda”). Recitals 1. Appointment of Director; Relationship of Company and Yehuda
12/34/56
EX-10.4
from 8-K 5 pages This Service Agreement (This “Agreement”) Is Made as of 5th of July, 2022, by and Between Raphael Pharmaceutical Inc. (The “Company”),, and Dr. Igal Louria Hayon (The “Cto”/So Called “Igal”). Recitals 1. Appointment of Igal to Be Cto & Director; Relationship of Company and Igal
12/34/56
EX-10.3
from 8-K 5 pages This Operations Agreement (This “Agreement”) Is Made as of July 5th ,2022, by and Between Raphael Pharmaceutical Ltd. (The “Company”), and Guy Ofir & Co. Srl a Romanian Company No. J40/1123/2007 or Adv’ Guy Ofir I.D. 172910400069 (The “CFO, Legal Adviser & Director”). Recitals 1. Appointment of CFO, Legal Adviser & Director and It’s Relationship With the Company
12/34/56
EX-10.2
from 8-K 5 pages This Management and Operations Agreement (This “Agreement”) Is Made as of July 5th 2022, by and Between Raphael Pharmaceutical Ltd. (The “Company”), and Sheffa Enterprises, Inc., a New Jersey Corporation/ Shlomo Pilo (The “Manager”). Recitals 1. Appointment of Manager; Relationship of Company and the Manager
12/34/56
EX-10.1
from 8-K 3 pages This Service Agreement (This “Agreement”) Is Made as of 30th of June, 2022, by and Between Raphael Pharmaceutical Inc. (The “Company”), and Joseph Press (The “Adviser”/So Called “Joseph”). Recitals 1. Appointment of Joseph to Be Medical Adviser; Relationship of Company and Joseph
12/34/56
EX-10.6
from 10-12G/A 27 pages Sponsored Research Agreement With Rambam Med-Tech Ltd
12/34/56
EX-10.5
from 10-12G/A 18 pages Contractual Agreement Between Raphael Pharmaceutical Ltd. and Way of Life Cannabis Ltd
12/34/56
EX-10.4
from 10-12G/A 2 pages Services Agreement for Finance Services Between Raphael Pharmaceutical Ltd. and Shimony Yosef Certified Public Accountant (Isr.)
12/34/56
EX-10.3
from 10-12G/A 6 pages Consulting Agreement With Sheffa Enterprises, Inc
12/34/56
EX-10.2
from 10-12G/A 9 pages Form of Indemnification Agreement
12/34/56
EX-10.1
from 10-12G/A 47 pages Share Exchange Agreement by and Between Easy Energy, Inc. and Raphael Pharmaceutical Ltd
12/34/56